Home Determining Design Space and Scale Up Conditions in Roller Compaction
 

Keywords :   


Determining Design Space and Scale Up Conditions in Roller Compaction

2015-01-20 11:23:07| drugdiscoveryonline Downloads

By Prasad.VN Challapalli1, Manaud de Raspide2, Satish Kamath3, and Ram Kasina4 1 Pharmaceutical Development Services, Patheon Pharmaceuticals Inc. Cincinnati, OH USA 2 Actelion Pharmaceuticals, Ltd, Allschwil, Switzerland 3 GlaxoSmithKline, Parsippany, NJ, USA 4 McNeil Consumer Healthcare, Fort Washington, PA, USA ABSTRACT Roller compaction of low dose active pharmaceutical ingredients into solid dosages forms is quite challenging.  Ribbon porosity, tensile strength, mean granule size and surface area are key quality attributes that can affect downstream processing and final product performance. These parameters were evaluated in the present study to establish a design space and operational conditions for roller compaction of a placebo tablet blend that closely mimics the formulation requirements of low dose pharmaceutical active ingredients. This study also helps to minimize the API need that often in limited supply during early stage of drug development.

Tags: conditions design space scale

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »